Cardiovascular disease remains the biggest global cause of death, yet most people still do not discover their risk until very late in the process.
Cardiovascular disease
remains responsible for
deaths worldwide
In the UK
are living with heart or circulatory disease
Every
someone dies from cardiovascular disease
Relying on late symptoms or standard screening alone often leaves people unaware of their actual risk. Preventative cardiology allows you to understand what is happening now and what may develop over the next decade, so you can take informed action.
Led by Pete Williams, focusing on systems biology, root-cause investigation, and lifestyle-driven interventions.
Led by Professor Rasha Al-Lamee, offering advanced diagnostics, imaging, and medical expertise.
Professor Rasha Al-Lamee & Pete Williams
More than 20 years of clinical functional medicine experience
A fully IFM Certified team of practitioners
Expertise in cardiovascular risk, metabolic health, brain health, performance, and long-term resilience
A systems-based method that connects your symptoms, your biology, and your environment into one coherent picture
We work beyond surface-level results and build a strategy that fits your life, your biology, and your goals.
For individuals, especially those with a family history of heart disease, early metabolic changes, chronic stress, or a desire to protect long-term health.
We identify early biological patterns, then help you build the foundations of cardiovascular resilience.
For individuals with raised cholesterol, elevated ApoB, hypertension, inflammation, or early signs of endothelial dysfunction.
We help you understand the mechanisms behind these findings and provide targeted nutritional, metabolic, and lifestyle strategies. When appropriate, pharmacological options are discussed with our cardiology partners.
For those already living with cardiovascular concerns.
We work alongside your conventional care team to optimise lifestyle factors, improve metabolic balance, and support healthy vascular function. Our focus is to strengthen the areas of physiology that medicines alone cannot influence.
It usually appears as part of a wider metabolic, inflammatory, and lifestyle pattern. These examples reflect the types of individuals who come to our clinic and the underlying mechanisms we often uncover.
Routine tests suggested borderline risk, yet advanced analysis showed elevated ApoB, insulin resistance, and subtle chronic inflammation. Advanced imaging (CTCA) indicated soft plaque within a major coronary artery. Lipid-lowering medication alongside targeted metabolic support and personalised lifestyle guidance was advised as a long-term strategy.
Experiencing fluctuating blood pressure, sleep disruption, increased abdominal weight, and rising cholesterol. Her symptoms were linked to hormonal transition, a period when cardiovascular risk increases significantly. A personalised programme combining nutrition, nervous system regulation, exercise, and cardiovascular conditioning restored stability and reduced risk.
Standard blood tests appeared normal, yet deeper investigation revealed elevated ApoB, vascular inflammation, poor recovery patterns, and low-grade inflammation. Non-invasive imaging (CIMT) was used as a baseline guide for future risk, with additional cardiology consultation. By addressing stress physiology, sleep, lipids, and movement, his long-term trajectory shifted. If lifestyle change alone is insufficient, personalised medication strategies are introduced.
• Genetic risk
• Chronic inflammation
• Oxidative stress
• Insulin resistance and glycaemic instability
• Gut and microbiome disruption
• Hormonal shifts
• Autonomic imbalance and stress physiology
